(Q34128361)

31 July 2017

title

Efficacy of memantine in PDD and DLB: an extension study including washout and open-label treatment (English)

1 reference

31 July 2017

3

1 reference

31 July 2017

6

D Aarsland

1 reference

31 July 2017

7

E Londos

1 reference

31 July 2017

5

L Minthon

1 reference

31 July 2017

2

C Ballard

1 reference

31 July 2017

C Johansson

1

1 reference

31 July 2017

S Palmqvist

series ordinal

4

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 February 2011

1 reference

International Journal of Geriatric Psychiatry

31 July 2017

published in

1 reference

31 July 2017

volume

26

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

206-213

1 reference

Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.

31 July 2017

cites work

1 reference

A systematic review of prevalence studies of dementia in Parkinson's disease

21 January 2018

1 reference

Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease.

21 January 2018

1 reference

Abnormal metabotropic glutamate receptor expression and signaling in the cerebral cortex in diffuse Lewy body disease is associated with irregular alpha-synuclein/phospholipase C (PLCbeta1) interactions

21 January 2018

1 reference

Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease

21 January 2018

1 reference

Rivastigmine for dementia associated with Parkinson's disease

21 January 2018

1 reference

Global prevalence of dementia: a Delphi consensus study

21 January 2018

1 reference

21 January 2018

1 reference

How to diagnose dementia with Lewy bodies: state of the art.

21 January 2018

1 reference

Donepezil therapy in clinical practice: a randomized crossover study

21 January 2018

1 reference

Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan

21 January 2018

1 reference

Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease.

21 January 2018

1 reference

Randomized controlled trial of memantine in dementia associated with Parkinson's disease

21 January 2018

1 reference

Efficacy and safety of memantine in Lewy body dementia.

21 January 2018

1 reference

DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers

21 January 2018

1 reference

The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism

21 January 2018

1 reference

Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study

21 January 2018

1 reference

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

21 January 2018

1 reference

What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementia.

21 January 2018

1 reference

Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: an active treatment extension study

21 January 2018

1 reference

Memantine in moderate-to-severe Alzheimer's disease

21 January 2018

1 reference

Delusions and hallucinations in dementia with Lewy bodies: worsening with memantine.

21 January 2018

1 reference

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial

21 January 2018

1 reference

The UPDRS scale as a means of identifying extrapyramidal signs in patients suffering from dementia with Lewy bodies.

21 January 2018

1 reference

7 January 2021

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop.

1 reference

7 January 2021

The use of memantine in dementia with Lewy bodies.

1 reference

7 January 2021

Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study

1 reference

7 January 2021

Identifiers

DOI

10.1002/GPS.2516

1 reference

31 July 2017

1 reference